Federal contract award
75F40124P00387
CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ), QUALITY ASSURANCE SPECIALIST III
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $170.7K |
| Current contract value | $170.7K |
| Potential contract value / ceiling | $170.7K |
| Start date | Aug 22, 2024 |
| Current end date | Aug 29, 2025 |
| Potential end date | Aug 29, 2025 |
| Latest award activity | Aug 5, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 5, 2026 | P00002 | $-21.4K | CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ), QUALITY ASSURANCE SPECIALIST III - FY26 UDO INIATIVE |
| Jun 12, 2025 | P00001 | $0 | CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ), QUALITY ASSURANCE SPECIALIST III |
| Aug 22, 2024 | 0 | $192.1K | CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ), QUALITY ASSURANCE SPECIALIST III |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.